A non-invasive serum fibrosis marker panel can consistently select chronic hepatitis C patients with minimal stage (F0–F1) fibrosis from more advanced disease (F2–F4)

✍ Scribed by K. Patel; C. Hezode; S.C. Gordon; I.M. Jacobson; J.-M. Pawlotsky; E. Oh; K.M. Smith; J.G. McHutchison

• Book ID: 117372645
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 319 KB
• Volume: 38
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(03)80762-6